Modifiable risk factors such as self-efficacy, sleep disturbances, and pain severity were associated with disability risk among patients with chronic LBP.

Why did Oregon's new $1.068 billion Public University Support Fund for 2025-27 disappoint University of Oregon and other ...

Every 1% cut in central bank interest rates gives Russia's VTB Bank an extra 20 billion roubles ($250 million) in net profit, ...

An apartment complex public hearing morphed into a discussion over whether the city of Sarasota's affordable housing ...

Tesla (NasdaqGS:TSLA) recently announced its Q2 2025 production results, highlighting the manufacture of 410,244 vehicles and ...

With 32-man rosters and a representative required for every team, there are inevitably a few surprise selections to the MLB ...

Europe isn’t just at risk of the direct effects of climate change, it is also exposed to the indirect effects of infectious ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced it has ...

The AAIB has managed to safely extract both the Crash Protection Module and the memory module, and successfully download all ...

Passport reports 94% of e-commerce leaders view in-country enablement as essential for profitability and resilience in global ...

The S&P 500 Index ($SPX) (SPY) today is up +0.58%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.89%, and the Nasdaq ...